APA (7th ed.) Citation

R, M., SM, G., S, H., G, M., MJ, W., & CA, S. (2023). Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK Inhibition. Journal of the National Comprehensive Cancer Network : JNCCN, 21(3), 232. https://doi.org/10.6004/jnccn.2022.7084

Chicago Style (17th ed.) Citation

R, Maniar, Gallitano SM, Husain S, Moazami G, Weiss MJ, and Shu CA. "Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK Inhibition." Journal of the National Comprehensive Cancer Network : JNCCN 21, no. 3 (2023): 232. https://doi.org/10.6004/jnccn.2022.7084.

MLA (9th ed.) Citation

R, Maniar, et al. "Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK Inhibition." Journal of the National Comprehensive Cancer Network : JNCCN, vol. 21, no. 3, 2023, p. 232, https://doi.org/10.6004/jnccn.2022.7084.